Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...
InnoCare Pharma Ltd, a Hong Kong-listed Chinese mainland biotech company, said on Thursday that its cancer drug ...
QBS72S, a LAT1-targeted agent, shows potential in treating leptomeningeal disease, improving survival rates in metastatic ...
Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new ...
The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...
Sophie Kinsella, best known for her Shopaholic series, died at the age of 55 after a battle with glioblastoma, an aggressive ...
A Phase 3 trial found that combining eflornithine with lomustine significantly improved survival for patients with recurrent ...
In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing ...
First patient in the world treated with Alpha DaRT® in the brain –- According to the National Brain Tumor Society, ...
Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric ...
While targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumors on a standard MRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback